SELECTIVE ANDROGEN RECEPTOR MODULATORS FOR TREATING DIABETES
摘要
<p>This invention provides use of a SARM compound or a composition comprising the same in treating and preventing muscle wasting in patients with non-small cell lung cancer (NSCLC); treating pre-cachexia or early cachexia (preventing muscle wasting in a cancer patient); treating and preventing loss of physical function due to cancer or cancer therapy; increase of physical function; and increasing survival in a patient with NSCLC.</p>
申请公布号
WO2012139093(A2)
申请公布日期
2012.10.11
申请号
WO2012US32707
申请日期
2012.04.09
申请人
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION;DALTON, JAMES, T.;DODSON, SHONTELLE;STEINER, MITCHELL, S.
发明人
DALTON, JAMES, T.;DODSON, SHONTELLE;STEINER, MITCHELL, S.